The main objective of VACDIVA is to solve the African swine fever (ASF) problem in Europe and affected countries, by developing three safe and effective vaccines for domestic pigs and wild boars, their companion DIVA tests and effective tools for control and eradication strategies in Europe.

 

Besides the commitment of the two industrial companies, VACDIVA counts with the expertise of two world ASF Reference Laboratories (WRC), the EU reference laboratory (EURL), six EU national Reference Laboratories (of 6 out of the 10 countries currently affected with ASF) and three prestigious ASF research institutions (FMV, MPG and WBVR). Dissemination, networking and training will be enlarged with the participation of pig producers (ECVC, COAG) and hunters (CIC as member of the Advisory Board).

NEWSLETTER

TWITTER FEED

VACDIVA
@ASFvacdivaOct 20
Role of the DNA-Binding Protein pA104R in ASFV Genome Packaging and as a Novel Target for Vaccine and Drug Developm… https://t.co/7xHTNgc2d3
VACDIVA
@ASFvacdivaOct 16
▶️Pig apartment blocks, the new trend in pig farms being developed in #China🇨🇳 to cope with the expansion of… https://t.co/To3lekBZmw